Serum lipids and prostate cancer.

Area of Science:

• Oncology
• Cardiovascular Health
• Biochemistry

Background:

• Existing literature presents conflicting findings on the relationship between serum lipid levels and prostate cancer.
• Some studies suggest an association, while others do not, necessitating further investigation.

Purpose of the Study:

• To investigate a potential association between serum lipid levels and prostate cancer at the time of diagnosis.
• To compare lipid profiles between prostate cancer patients and controls.

Main Methods:

• Serum levels of total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides were measured in 237 patients undergoing prostate biopsy (PSA 2-10 ng/ml).
• Patients were categorized into cases (cancer confirmed) and controls (no cancer).
• Logistic regression analysis and odds ratios were calculated to assess associations.

Main Results:

• Lower levels of LDL cholesterol and total cholesterol were observed in prostate cancer patients compared to controls.
• The difference was statistically significant for LDL cholesterol (p=0.010) and borderline for total cholesterol (p=0.050).
• Odds ratios indicated an increased likelihood of prostate cancer with low LDL cholesterol (1.983) and low total cholesterol (1.703).

Conclusions:

• Lower serum LDL cholesterol (<130 mg/dl) and total cholesterol (<200 mg/dl) levels appear to be associated with prostate cancer at diagnosis.
• These findings suggest a potential role for lipid profiles in prostate cancer risk assessment.